114 related articles for article (PubMed ID: 21368684)
1. Relationship between oral antihyperglycemic medication adherence and hospitalization, mortality, and healthcare costs in adult ambulatory care patients with type 2 diabetes in South Korea.
Hong JS; Kang HC
Med Care; 2011 Apr; 49(4):378-84. PubMed ID: 21368684
[TBL] [Abstract][Full Text] [Related]
2. Continuity of ambulatory care and health outcomes in adult patients with type 2 diabetes in Korea.
Hong JS; Kang HC
Health Policy; 2013 Feb; 109(2):158-65. PubMed ID: 23093021
[TBL] [Abstract][Full Text] [Related]
3. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
[TBL] [Abstract][Full Text] [Related]
4. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation of antihyperglycemic therapy and clinical outcomes after acute myocardial infarction in older patients with diabetes.
Lipska KJ; Wang Y; Kosiborod M; Masoudi FA; Havranek EP; Krumholz HM; Inzucchi SE
Circ Cardiovasc Qual Outcomes; 2010 May; 3(3):236-42. PubMed ID: 20354220
[TBL] [Abstract][Full Text] [Related]
6. Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes.
Mody R; Kalsekar I; Kavookjian J; Iyer S; Rajagopalan R; Pawar V
J Diabetes Complications; 2007; 21(2):75-83. PubMed ID: 17331855
[TBL] [Abstract][Full Text] [Related]
7. Relationship between continuity of ambulatory care and medication adherence in adult patients with type 2 diabetes in Korea: a longitudinal analysis.
Hong JS; Kang HC
Med Care; 2014 May; 52(5):446-53. PubMed ID: 24714582
[TBL] [Abstract][Full Text] [Related]
8. A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005.
Hansen RA; Farley JF; Droege M; Maciejewski ML
Clin Ther; 2010 Jul; 32(7):1308-19. PubMed ID: 20678679
[TBL] [Abstract][Full Text] [Related]
9. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
Hertz RP; Unger AN; Lustik MB
Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT
Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
[TBL] [Abstract][Full Text] [Related]
11. Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database.
Zhang Q; Rajagopalan S; Mavros P; Engel SS; Davies MJ; Yin D; Radican L
Curr Med Res Opin; 2010 Jul; 26(7):1697-703. PubMed ID: 20465367
[TBL] [Abstract][Full Text] [Related]
12. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients.
Karve S; Cleves MA; Helm M; Hudson TJ; West DS; Martin BC
Med Care; 2008 Nov; 46(11):1125-33. PubMed ID: 18953222
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported perceptions of side effects of antihyperglycemic medication and adherence to medication regimens in persons with diabetes mellitus.
Chao J; Nau DP; Aikens JE
Clin Ther; 2007 Jan; 29(1):177-80. PubMed ID: 17379058
[TBL] [Abstract][Full Text] [Related]
14. Relationship of compliance with hormone replacement therapy to short-term healthcare utilization in a managed care population.
Hurley JS; Frost EJ; Trinkaus KM; Buatti MC; Emmett KE
Am J Manag Care; 1998 Dec; 4(12):1691-8. PubMed ID: 10339101
[TBL] [Abstract][Full Text] [Related]
15. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.
Cole JA; Norman H; Weatherby LB; Walker AM
Pharmacotherapy; 2006 Aug; 26(8):1157-64. PubMed ID: 16863491
[TBL] [Abstract][Full Text] [Related]
16. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications.
Nau DP; Chao J; Aikens JE
Res Social Adm Pharm; 2005 Sep; 1(3):378-88. PubMed ID: 17138485
[TBL] [Abstract][Full Text] [Related]
17. The effect of depression on health care utilization and costs in patients with type 2 diabetes.
Kalsekar ID; Madhavan SM; Amonkar MM; Scott V; Douglas SM; Makela E
Manag Care Interface; 2006 Mar; 19(3):39-46. PubMed ID: 16583789
[TBL] [Abstract][Full Text] [Related]
18. Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration.
Kahler KH; Rajan M; Rhoads GG; Safford MM; Demissie K; Lu SE; Pogach LM
Diabetes Care; 2007 Jul; 30(7):1689-93. PubMed ID: 17440170
[TBL] [Abstract][Full Text] [Related]
19. In-hospital management of type 2 diabetes mellitus.
Lien LF; Angelyn Bethel M; Feinglos MN
Med Clin North Am; 2004 Jul; 88(4):1085-105, xii. PubMed ID: 15308391
[TBL] [Abstract][Full Text] [Related]
20. Excess health care costs of obesity in adults with diabetes mellitus: a claims data analysis.
von Lengerke T; Hagenmeyer EG; Gothe H; Schiffhorst G; Happich M; Häussler B
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):496-504. PubMed ID: 20496315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
